Position in HALO
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$59,072,012
-$32,835,760 QoQ
Shares Held
914,003
-33.1% QoQ
Ownership
0.771%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 83.82456075089469.ToString("F0")%
Shared 0.ToString("F0")%
None 16.17543924910531.ToString("F0")%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Derivatives in HALO
reported options exposure · as of Jun 30, 2020CallValue
$7,453,180
CallShares
278,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS Group AG holds $8,307,109,707 across 562 Biotechnology names. HALO ranks #37 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
22,619,472 | $626,559,372 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
5,177,796 | $545,739,697 | |
| 3 | ABVX |
Abivax S.A.
|
4,547,406 | $506,353,656 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
4,386,791 | $426,615,424 | |
| 5 | INSM |
INSMED Inc
|
1,737,481 | $284,112,890 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
630,618 | $281,596,158 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
6,206,681 | $249,694,775 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
299,979 | $231,775,770 |
All Filings in HALO
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $59,072,012 | 914,003 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $91,907,772 | 1,365,643 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $216,041,377 | 2,945,751 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $79,298,611 | 1,524,387 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $22,412,047 | 351,231 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $29,583,583 | 618,774 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $20,350,307 | 355,526 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $18,626,179 | 355,733 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $13,478,504 | 331,330 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $15,353,404 | 415,406 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $7,177,321 | 187,888 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $7,406,144 | 205,327 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $6,840,553 | 179,119 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $8,386,148 | 147,384 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $1,944,458 | 49,177 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $3,470,368 | 78,872 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $3,624,852 | 90,894 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $7,089,545 | 176,313 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $6,622,703 | 162,800 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,768,711 | 82,993 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $6,747,526 | 161,850 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $4,592,819 | 107,535 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $1,848,271 | 70,330 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $1,943,724 | 72,500 | Shares | Defined | 2020-07-31 | |
| 2020-06-30 | $7,453,180 | 278,000 | Call | Defined | 2020-07-31 | |
| 2020-03-31 | $178,101 | 9,900 | Call | Defined | 2020-05-01 | |
| 2020-03-31 | $2,114,723 | 117,550 | Shares | Defined | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||